Navellier & Associates Inc Bio N Tech Se Transaction History

Navellier & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$126.25 - $231.85 $2.86 Million - $5.25 Million	-22,652 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $93,155 - $155,883	430 Added 1.94%	22,652 $5.84 Million
Q3 2021 Oct 28, 2021	SELL	$205.93 - $447.23 $169,892 - $368,964	-825 Reduced 3.58%	22,222 $6.07 Million
Q2 2021 Aug 09, 2021	BUY	$113.32 - $241.49 $2.61 Million - $5.57 Million	23,047 New	23,047 $5.16 Million

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.3B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.